Memo Therapeutics examines treatment for BK polyomavirus in kidney transplant recipients - Healio

Memo Therapeutics AG announced the initiation of a phase 1 clinical study to examine MTX-005 against BK polyomavirus infection among kidney transplant patients.“MTX-005 could be a game-changer for patients who are currently seriously underserved. The an…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio Memo Therapeutics AG announced the initi… [+1476 chars]

full article...